Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tiagabine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tiagabine 5mg tablets
0408010ABAAAAAA
|
Tiagabine | Tiagabine | Central Nervous System | 169 |
|
Tiagabine 10mg tablets
0408010ABAAABAB
|
Tiagabine | Tiagabine | Central Nervous System | 146 |
|
Tiagabine 15mg tablets
0408010ABAAACAC
|
Tiagabine | Tiagabine | Central Nervous System | 84 |
|
Gabitril 10mg tablets
0408010ABBBABAB
|
Gabitril | Tiagabine | Central Nervous System | 14 |
|
Gabitril 15mg tablets
0408010ABBBACAC
|
Gabitril | Tiagabine | Central Nervous System | 14 |
|
Gabitril 5mg tablets
0408010ABBBAAAA
|
Gabitril | Tiagabine | Central Nervous System | 6 |
|
Tiagabine 2.5mg/5ml oral suspension
0408010ABAAAEAE
|
Tiagabine | Tiagabine | Central Nervous System | 4 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.